Nothing Special   »   [go: up one dir, main page]

WO1997026917A1 - Composition for treating skin affections and process for its preparation - Google Patents

Composition for treating skin affections and process for its preparation Download PDF

Info

Publication number
WO1997026917A1
WO1997026917A1 PCT/EP1997/000269 EP9700269W WO9726917A1 WO 1997026917 A1 WO1997026917 A1 WO 1997026917A1 EP 9700269 W EP9700269 W EP 9700269W WO 9726917 A1 WO9726917 A1 WO 9726917A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
amount
composition
relative
complete
Prior art date
Application number
PCT/EP1997/000269
Other languages
French (fr)
Inventor
Johannes Schreuder
Original Assignee
Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. filed Critical Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V.
Priority to EP97902196A priority Critical patent/EP0876159A1/en
Priority to AU15936/97A priority patent/AU1593697A/en
Publication of WO1997026917A1 publication Critical patent/WO1997026917A1/en
Priority to NO983215A priority patent/NO983215L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/064Water-in-oil emulsions, e.g. Water-in-silicone emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Definitions

  • the invention relates to a composition for treating skin affections, to a process for its preparation, and to the application of said composition.
  • the invention relates to a multifunctional composition for the treatment of chapped, sore and/or inflamed skin parts such as lips, nose opening edges, eyelids and the like, while such composition does not contain ingredients which may disturb the biological equilibrium of said skin part.
  • composition of the invention heals, relieves and softens chapped, sore or inflamed lips, nose opening edges, eyelids and the like, affected by a Herpes Simplex virus type, such as fever blister and/or affections by winter weather and/or intensive sunshine.
  • compositions have already been proposed for this purpose n the course of the last decade.
  • prior art compositions have the disadvantage that they cause a burning, irritated and/or inflamed feeling, usually caused by constituents which significantly disturb the biological equilibrium of the affected skin parts .
  • said prior art compositions usually d d not relieve the irritation or even pam, and certainly did not heal the affected skin in an efficient way.
  • one object of the present invention is to provide a multifunctional composition for the treatment of chapped, sore and/or inflamed skin parts such as lips, nose opening edges, eyelids and the like, which during application does not cause a burning, irritated and/or inflamed feeling and which facilitate an almost immediate relief and healing, and the constituents of which do not disturb the biological equilibrium of the affected sk n parts.
  • Another object of the present invention is to provide a process for the preparation of said composition.
  • the present invention provides a multifunctional composition for the treatment of chapped, sore and/or inflamed skin parts such as lips, nose opening edges, eyelids and the like, characterised by at least the following ingredients :
  • An oil fraction comprising straight or branched paraffinic oils, having from 10 to 60 carbon atoms in the chain, and preferably from 15 to 25 carbon atoms, in an amount of from 10 to 60 % by weight, and preferably from 15 to 25 % by weight, relative to the weight of the complete composition, having a boiling range between 100 and 500°C at atmospheric pressure and a viscosity of preferably at most 35 mm 2 /s, preferably of at most 30 mm ⁇ /s, at 25°C, while the paraffinic oils may optionally be mixed with esters of higher natural fatty acids, which are preferably unsaturated, and of higher natural aliphatic alcohols, which are preferably unsaturated, of at most 20 carbon atoms in the chain, in an amount of from 0 to 2 % by weight, and preferably from 0.5 to 2 % by weight, relative to the weight of the complete composition;
  • n, m and p represent the same or different integers of from 0 to 20, under the condition that at least one of the symbols n, m and p has a value of from 5 to 20, preferably from 7 to 15, and wherein R represents the same or different saturated or unsaturated, and preferably the same unsaturated hydrocarbon residue, derived from vegetable or animal oil (e.g. Tagat TO) .
  • the weight ratio between the amount of mono- and/or diglycerides on the one hand and of the ethoxylated triglycerides on the other hand may vary from 10 to 100 parts by weight of mono- and/or diglycerides per part by weight of ethoxylated triglycerides and preferably from 15 to 50 parts by weight of mono- and/or diglycerides per part by weight of ethoxylated triglycerides, whereas the amount of the complete emulsifying system, relative to the weight of the complete composition, may vary from 0.5 to 3.5 % by weight and preferably from 2 to 3 % by weight, relative to the weight of the total composition.
  • Vitamin E or a derivative thereof which may easily provide vitamin E itself by conversion on the affected skin, such as Covitol (trademark), in an amount of from 0.1 to 5 % by weight, and preferably from 0.5 to 4 % by weight, and most preferably from 1 to 3 % by weight, relative to the weight of the total composition;
  • Methionine in the form of its L or D isomer or mixtures thereof, preferably L-methionine, or a derivative thereof which may easily provide methionine by conversion on the affected skin, in an amount of from 0.1 to 5 % by weight and preferably from 0.5 to 3 % by weight and most preferably from 1 to 2 % by weight, relative to the weight of the complete composition;
  • a pH regulating system to adjust the pH of a present aqueous phase including at least demineralized water and methionine, to be in the range of from 4.4 to 5.0 and more preferably from 4.5 to 4.9, comprising preferably citric acid, zinc carbonate and sodium hydroxide, or citric acid, zinc carbonate and potassium hydroxide, each of the components occurring n an amount of from 0.05 to 2.5 % by weight, relative to the weight of the complete composition.
  • citric acid, zinc carbonate and sodium hydroxide occur in amounts of from 0.5 to 2 % by weight, from 0.05 to 0.2 % by weight and from 0.5 to 1 % by weight, respectively, relative to the weight of the complete composition.
  • the pH of the final complete composition is adjusted by said pH regulating system to the range of from 4.8 to 5.1 with citric acid or sodium hydroxide.
  • a stabilizer consisting of at least one montmorillonite, the free oxygen sites of which are occupied by quaternary groups (quaternary modified montmorillonites) .
  • Such stabilizers which are preferably included are Bentone (trademark) or Propoloid (trademark) .
  • Said stabilizers are included in the composition in amounts of from 0.1 to 1.5 % by weight and preferably from 0.5 to 0.7 % by weight, relative to the weight of the complete composition.
  • demineralized water is used in amounts of from 65 to 75 % by weight, relative to the weight of the complete composition.
  • one or more secondary ingredients also can be present in the complete compositions, such as;..
  • esters of parahydroxy benzoic acid may occur in the oily phase as well as in the aqueous phase.
  • the methyl and/or the (iso)propyl ester is present in an amount of from 0.1 to 1 % by weight and most preferably in amounts from 0.5 to 0.7 % by weight, relative to the weight of the complete composition.
  • the preservatives occur in the aqueous phase in a total amount of from 0.3 to 0.4 % by weight;
  • (l) Glycerol in an amount of from 1 to 4 % by weight and more preferably from 1 to 3 % by weight.
  • a gel forming agent such as carraghenate, preferably consisting of a polysaccharide with sulphonic ac d residues, and preferably a gel forming agent of natural origin such as one derived from seaweeds .
  • the sulphonic acid residues have optionally been converted into salts or esters of glycol, propylen glycol and glycerol (resulting in the so-called modified carraghenates) .
  • the gel forming agent e. g. the carraghenates, n amounts of from 0.1 to 5 % by weight, relative to the weight of the complete composition and preferably from 0.5 to 2 % by weight, cause a gel structure m the final composition.
  • a complete composition shows a viscosity of 200 to 5000 mPa-s (centipoises) at 25°C, enabling an adequate application of the composition.
  • the carraghenate may be completely or partially replaced by alternative gel forming means, such as carboxy methyl cellulose, esterified by polyacrylic acid e. g Carbopol (trademark), or hydroxy ethyl cellulose, n amounts which provide the viscosity values in the above range.
  • (k) Perfume in an amount of from 0.1 to 2 % by weight, preferably 0.1 to 0.3 % by weight, relative to the weight of the complete composition. Examples of such perfumes are sage oil or jacaranda.
  • At least one protein obtainable from aqueous extraction of plants, such as aloe vera, in amounts of from 0.1 to 0.5 % by weight, relative to the weight of the complete composition, and preferably from 0.1 to 0.3 % by weight.
  • compositions according to the present invention as specified hereinbefore are characterized by a relatively low viscosity and high stability, which guarantees an easy application, without a 'greasy” feeling or stickiness, due to the fast penetration into the skin tissue, and moreover by a healing, relieving and softening activity.
  • Another aspect of the present invention is formed by a process for the preparation of the hereinbefore specified compositions .
  • the complete continuous oily phase is prepared in one or more steps of said process, composed of oil fractions, the optional esters of fatty acids and alcohols, the emulsifying system, the stabilizer, vitamin E or a derivative thereof and the optional preservative, wherein in one or more separate steps at least one dispersed aqueous phase is prepared, composed of demmeralized water, citric acid or a citrate, zinc carbonate and sodium or potassium hydroxide, methionine, glycerol, gel forming agent, protein, and preservative and perfume
  • composition according to the present invention is prepared by composing both phases and mixing them together at a temperature of 10 to 40°C, followed by additional stirring and homogenizing until an average particle size of the dispersed aqueous phase of at most 5 ⁇ and preferably smaller than 3 ⁇ is reached, while the pH of the final complete composition is adjusted within the range of from 4.8 to 5.1.
  • a first step the oil fraction, the optional esters of unsaturated fatty acids and alcohols, the emulsifying system and the stabilizer are mixed and homogenized at a temperature from 60 to 90°C, whereafter the homogeneous mixture is cooled back to a temperature of at most 30°C.
  • the cooled mixture is mixed in a second step with vitamin E or a derivative thereof which can easily be transformed nto said vitamin, and with the perfume, until a homogeneous mixture is obtained.
  • the aqueous phase is normally prepared at a temperature of from 10 to 40°C and preferably from 20 to 30°C by subsequent addition of demineralized water n an amount of about one third of the total amount n the final composition, of the citric acid, of zinc carbonate and of sodium or potassium hydroxide under gently stirring until complete dissolution.
  • the pH of the homogeneous solution is adjusted to the range of from 4.6 to 4.8 by addition of sodium or potassium hydroxide or citric acid.
  • the remainder of the desired total amount of water, methionine, glycerol, carraghenate, preservative and protein are added whereafter the pH is again adjusted to the range of from 4.5 to 4.8.
  • the finally obtained aqueous phase is added to the oily phase under stirring vigorously and subsequent homogenizing at a temperature in the range of from 10 to 40°C and preferably from 20 to 30°C, whereafter the pH of the complete dispersion, having dispersed aqueous phase particles cf an average size of at most 5 ⁇ , is in the range of from 4.9 to 5.1.
  • Another aspect of the present invention is formed by the application of the before specified composition, i. e. the treatment of the chapped, sore and/or inflamed skin of lips and nose opening edges, eyelids and the like, with the hereinbefore specified composition.
  • Such an application comprises a method being usual for said compositions, characterized by application and evenly spreading the composition on the skin area involved, in an amount of from 20 to 100 ml/m 2 skin area.
  • This treatment should preferably be performed 2 to 3 times a day.
  • paraffinic oil I boiling range 295-390°C
  • paraffinic oil II boiling range 290-500°C
  • Tegomuls SB (trademark) 2.280 kg
  • the homogeneous mixture is cooled to 30°C and mixed with
  • An aqueous phase is prepared by mixing together:
  • the pH of the aqueous solution is adjusted with either citric acid or sodium hydroxide to a pH of from 4.60 to 4.80, and
  • the batches III and IV are combined and mixed with the mixture of batches I and II under vigorously stirring and homogenzmg until an average particle size of the dispersed phase of 3 ⁇ is obtained, whereafter the pH of the complete composition was 5.0.
  • Example 1 a composition was prepared from the following ingredients:
  • paraffinic oil I 14.700 kg paraffinic oil II 3.200 kg mono- and diglycerides 2.100 kg
  • composition was prepared from the following ingredients:
  • compositions show a high stability and a fast healing, relieving and softening activity when applied on sore, chapped and/or inflamed skin of lips and nose opening edges .

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

There is described a multifunctional composition for the treatment of chapped, sore and/or inflamed skin parts, comprising at least the following ingredients: (a) an oil fraction comprising straight or branched paraffinic oils, having from 10 to 60 carbon atoms in the chain; (b) an emulsifying system mainly comprising (b,i) mono- and/or diglycerides of high unsaturated and saturated fatty acids, and (b,ii) ethoxylated triglycerides, esterified with fatty acids; (c) vitamin E, or a derivative thereof; (d) methionine; (e) a pH regulating system; (f) a stabilizer consisting of montmorillonite; (g) water ad 100 % by weight, and the preparation and use of said composition.

Description

COMPOSITION FOR TREATING SKIN AFFECTIONS AND PROCESS FOR ITS PREPARATION. The invention relates to a composition for treating skin affections, to a process for its preparation, and to the application of said composition. In particular the invention relates to a multifunctional composition for the treatment of chapped, sore and/or inflamed skin parts such as lips, nose opening edges, eyelids and the like, while such composition does not contain ingredients which may disturb the biological equilibrium of said skin part.
Specifically, the composition of the invention heals, relieves and softens chapped, sore or inflamed lips, nose opening edges, eyelids and the like, affected by a Herpes Simplex virus type, such as fever blister and/or affections by winter weather and/or intensive sunshine.
The before mentioned affections can also be caused by flu or menstruation.
Many compositions have already been proposed for this purpose n the course of the last decade. However, the .up to now available prior art compositions have the disadvantage that they cause a burning, irritated and/or inflamed feeling, usually caused by constituents which significantly disturb the biological equilibrium of the affected skin parts . As a consequence, said prior art compositions usually d d not relieve the irritation or even pam, and certainly did not heal the affected skin in an efficient way.
Therefore one object of the present invention is to provide a multifunctional composition for the treatment of chapped, sore and/or inflamed skin parts such as lips, nose opening edges, eyelids and the like, which during application does not cause a burning, irritated and/or inflamed feeling and which facilitate an almost immediate relief and healing, and the constituents of which do not disturb the biological equilibrium of the affected sk n parts. Another object of the present invention is to provide a process for the preparation of said composition.
As a result of extensive and lengthy research and experimentation, such compositions have surprisingly been found.
Accordingly, the present invention provides a multifunctional composition for the treatment of chapped, sore and/or inflamed skin parts such as lips, nose opening edges, eyelids and the like, characterised by at least the following ingredients :
{a) An oil fraction comprising straight or branched paraffinic oils, having from 10 to 60 carbon atoms in the chain, and preferably from 15 to 25 carbon atoms, in an amount of from 10 to 60 % by weight, and preferably from 15 to 25 % by weight, relative to the weight of the complete composition, having a boiling range between 100 and 500°C at atmospheric pressure and a viscosity of preferably at most 35 mm2/s, preferably of at most 30 mm^/s, at 25°C, while the paraffinic oils may optionally be mixed with esters of higher natural fatty acids, which are preferably unsaturated, and of higher natural aliphatic alcohols, which are preferably unsaturated, of at most 20 carbon atoms in the chain, in an amount of from 0 to 2 % by weight, and preferably from 0.5 to 2 % by weight, relative to the weight of the complete composition;
(b) An emulsifying system mainly comprising
(b,i) mono- and/or diglycerides of higher unsaturated and saturated fatty acids, in an amount of from
0.5 to 3 % by weight, relative to the weight of the complete composition, e. g. Tegomuls (trademark), and
(b,ii) ethoxylated triglycerides esterified with fatty acids, according to the general formula
Figure imgf000005_0001
wherein n, m and p represent the same or different integers of from 0 to 20, under the condition that at least one of the symbols n, m and p has a value of from 5 to 20, preferably from 7 to 15, and wherein R represents the same or different saturated or unsaturated, and preferably the same unsaturated hydrocarbon residue, derived from vegetable or animal oil (e.g. Tagat TO) . The weight ratio between the amount of mono- and/or diglycerides on the one hand and of the ethoxylated triglycerides on the other hand may vary from 10 to 100 parts by weight of mono- and/or diglycerides per part by weight of ethoxylated triglycerides and preferably from 15 to 50 parts by weight of mono- and/or diglycerides per part by weight of ethoxylated triglycerides, whereas the amount of the complete emulsifying system, relative to the weight of the complete composition, may vary from 0.5 to 3.5 % by weight and preferably from 2 to 3 % by weight, relative to the weight of the total composition. (c) Vitamin E, or a derivative thereof which may easily provide vitamin E itself by conversion on the affected skin, such as Covitol (trademark), in an amount of from 0.1 to 5 % by weight, and preferably from 0.5 to 4 % by weight, and most preferably from 1 to 3 % by weight, relative to the weight of the total composition;
(d) Methionine, in the form of its L or D isomer or mixtures thereof, preferably L-methionine, or a derivative thereof which may easily provide methionine by conversion on the affected skin, in an amount of from 0.1 to 5 % by weight and preferably from 0.5 to 3 % by weight and most preferably from 1 to 2 % by weight, relative to the weight of the complete composition;
(e) A pH regulating system to adjust the pH of a present aqueous phase, including at least demineralized water and methionine, to be in the range of from 4.4 to 5.0 and more preferably from 4.5 to 4.9, comprising preferably citric acid, zinc carbonate and sodium hydroxide, or citric acid, zinc carbonate and potassium hydroxide, each of the components occurring n an amount of from 0.05 to 2.5 % by weight, relative to the weight of the complete composition.
More preferably citric acid, zinc carbonate and sodium hydroxide occur in amounts of from 0.5 to 2 % by weight, from 0.05 to 0.2 % by weight and from 0.5 to 1 % by weight, respectively, relative to the weight of the complete composition.
The pH of the final complete composition is adjusted by said pH regulating system to the range of from 4.8 to 5.1 with citric acid or sodium hydroxide. (f) A stabilizer, consisting of at least one montmorillonite, the free oxygen sites of which are occupied by quaternary groups (quaternary modified montmorillonites) . Examples of such stabilizers which are preferably included are Bentone (trademark) or Propoloid (trademark) . Said stabilizers are included in the composition in amounts of from 0.1 to 1.5 % by weight and preferably from 0.5 to 0.7 % by weight, relative to the weight of the complete composition.
(g) Water ad 100 % by weight.
Preferably demineralized water is used in amounts of from 65 to 75 % by weight, relative to the weight of the complete composition.
In addition to the before mentioned primary indispensable ingredients, one or more secondary ingredients also can be present in the complete compositions, such as;..
(h) At least one preservative.
Preferably different types are present in the continuous ultimately formed oily phase.
For example esters of parahydroxy benzoic acid may occur in the oily phase as well as in the aqueous phase.
Preferably the methyl and/or the (iso)propyl ester is present in an amount of from 0.1 to 1 % by weight and most preferably in amounts from 0.5 to 0.7 % by weight, relative to the weight of the complete composition.
Most preferably mixtures of methyl, propyl and butyl p-hydroxybenzoate are used, e.g. Phenonip (trademark) . It will be appreciated by a person skilled in the art, that these before mentioned preservatives may be completely or partially replaced by other preservatives, e.g. Germall II (trademark) or Hydroconserv (trademark), and if so, said other preservatives are present preferably in an amount of from 0.1 to 0.5 % by weight.
More preferably the preservatives occur in the aqueous phase in a total amount of from 0.3 to 0.4 % by weight;
(l) Glycerol, in an amount of from 1 to 4 % by weight and more preferably from 1 to 3 % by weight.
( ] ) A gel forming agent, such as carraghenate, preferably consisting of a polysaccharide with sulphonic ac d residues, and preferably a gel forming agent of natural origin such as one derived from seaweeds . The sulphonic acid residues have optionally been converted into salts or esters of glycol, propylen glycol and glycerol (resulting in the so-called modified carraghenates) .
The gel forming agent, e. g. the carraghenates, n amounts of from 0.1 to 5 % by weight, relative to the weight of the complete composition and preferably from 0.5 to 2 % by weight, cause a gel structure m the final composition. Such a complete composition shows a viscosity of 200 to 5000 mPa-s (centipoises) at 25°C, enabling an adequate application of the composition.
It will be appreciated by a person skilled in the art that the carraghenate may be completely or partially replaced by alternative gel forming means, such as carboxy methyl cellulose, esterified by polyacrylic acid e. g Carbopol (trademark), or hydroxy ethyl cellulose, n amounts which provide the viscosity values in the above range. (k) Perfume, in an amount of from 0.1 to 2 % by weight, preferably 0.1 to 0.3 % by weight, relative to the weight of the complete composition. Examples of such perfumes are sage oil or jacaranda.
(1) at least one protein, obtainable from aqueous extraction of plants, such as aloe vera, in amounts of from 0.1 to 0.5 % by weight, relative to the weight of the complete composition, and preferably from 0.1 to 0.3 % by weight.
The compositions according to the present invention as specified hereinbefore, are characterized by a relatively low viscosity and high stability, which guarantees an easy application, without a 'greasy" feeling or stickiness, due to the fast penetration into the skin tissue, and moreover by a healing, relieving and softening activity.
Another aspect of the present invention is formed by a process for the preparation of the hereinbefore specified compositions .
The complete continuous oily phase is prepared in one or more steps of said process, composed of oil fractions, the optional esters of fatty acids and alcohols, the emulsifying system, the stabilizer, vitamin E or a derivative thereof and the optional preservative, wherein in one or more separate steps at least one dispersed aqueous phase is prepared, composed of demmeralized water, citric acid or a citrate, zinc carbonate and sodium or potassium hydroxide, methionine, glycerol, gel forming agent, protein, and preservative and perfume
The composition according to the present invention is prepared by composing both phases and mixing them together at a temperature of 10 to 40°C, followed by additional stirring and homogenizing until an average particle size of the dispersed aqueous phase of at most 5 μ and preferably smaller than 3 μ is reached, while the pH of the final complete composition is adjusted within the range of from 4.8 to 5.1.
According to a preferred embodiment of the process to prepare the composition of the present invention, n a first step the oil fraction, the optional esters of unsaturated fatty acids and alcohols, the emulsifying system and the stabilizer are mixed and homogenized at a temperature from 60 to 90°C, whereafter the homogeneous mixture is cooled back to a temperature of at most 30°C.
The cooled mixture is mixed in a second step with vitamin E or a derivative thereof which can easily be transformed nto said vitamin, and with the perfume, until a homogeneous mixture is obtained.
The aqueous phase is normally prepared at a temperature of from 10 to 40°C and preferably from 20 to 30°C by subsequent addition of demineralized water n an amount of about one third of the total amount n the final composition, of the citric acid, of zinc carbonate and of sodium or potassium hydroxide under gently stirring until complete dissolution. If necessary the pH of the homogeneous solution is adjusted to the range of from 4.6 to 4.8 by addition of sodium or potassium hydroxide or citric acid. To this aqueous solution the remainder of the desired total amount of water, methionine, glycerol, carraghenate, preservative and protein are added whereafter the pH is again adjusted to the range of from 4.5 to 4.8.
The finally obtained aqueous phase is added to the oily phase under stirring vigorously and subsequent homogenizing at a temperature in the range of from 10 to 40°C and preferably from 20 to 30°C, whereafter the pH of the complete dispersion, having dispersed aqueous phase particles cf an average size of at most 5 μ, is in the range of from 4.9 to 5.1.
Another aspect of the present invention is formed by the application of the before specified composition, i. e. the treatment of the chapped, sore and/or inflamed skin of lips and nose opening edges, eyelids and the like, with the hereinbefore specified composition.
Such an application comprises a method being usual for said compositions, characterized by application and evenly spreading the composition on the skin area involved, in an amount of from 20 to 100 ml/m2 skin area.
This treatment should preferably be performed 2 to 3 times a day.
The invention is illustrated by the following examples, however without restricting its scope to these specific embodiments .
Example 1
Under stirring and heating to a temperature of 80°C the following ingredients are combined:
paraffinic oil I, boiling range 295-390°C
Shell Ondina 15 (trademark) 10.000 kg
paraffinic oil II, boiling range 290-500°C
Shell Ondina 68 (trademark) 6.000 kg
mono- and diglycerides, Tegomuls SB (trademark) 2.280 kg
quaternary modified montmorillonite, Bentone 38 (trademark) 0.660 kg
Batch
I oleyl decalate, Cetiol V (trademark) 1.000 kg
ethoxylated triglycerides, .Tagat TO (trademark) 0.050 kg
The homogeneous mixture is cooled to 30°C and mixed with
vitamin E, Covitol (trademark; 2.000 kg
Batch perfume (sage oil) 0.125 kg II perfume (jacaranda) 0.075 kg
to a homogeneous mixture. An aqueous phase is prepared by mixing together:
f water 21.417 kg
I Batch i citric acid 1.133 kg
III ( zinc carbonate BCP49 0.700 kg
[ sodiumhydroxide (97 %) 0.150 kg
whereafter the pH of the aqueous solution is adjusted with either citric acid or sodium hydroxide to a pH of from 4.60 to 4.80, and
( water 49.610 kg L-methionme 1.000 kg
Batch glycerol 1.26 2.000 kg IV carraghenate, Aubygum X2 (trademark; 1.000 kg preservatives 0.600 kg protein, aloe vera 0.200 kg
The batches III and IV are combined and mixed with the mixture of batches I and II under vigorously stirring and homogenzmg until an average particle size of the dispersed phase of 3 μ is obtained, whereafter the pH of the complete composition was 5.0.
Example 2
According to the same procedure as described m Example 1, a composition was prepared from the following ingredients:
paraffinic oil I 14.700 kg paraffinic oil II 3.200 kg mono- and diglycerides 2.100 kg
Batch quaternary modified montmorillonite 0.650 kg
I ethoxylated triglycerides 0.050 kg and vitamin E 2.200 kg
Batch perfume (sage oil) 0.140 kg
II perfume (jacaranda) 0.075 kg and
/'water 21.340 kg
Batch citric acid 1.130 kg
III zinc carbonate 0.700 kg potassium hydroxide (97 %) 0.155 kg and water 48.105 kg
L-methionine 1.300 kg glycerol 1.800 kg
Batch carraghenate 1.200 kg
IV preservatives 0.700 kg protein 0.400 kg
ExamDle 3
According to the same procedure as described in Example 1, a composition was prepared from the following ingredients:
paraffinic oil I 12.200 kg paraffinic oil II 3.200 kg
Batch mono- and diglycerides 2.200 kg
I ethoxylated triglycerides 0.055 kg quaternary modified montmorillonite 0.645 kg and fvitamin E 2.100 kg
Batch perfume (sage oil) 0.140 kg II perfume (jacaranda) 0.080 kg and water 21.500 kg
Batch citric acid 1.130 kg III zinc carbonate 0.700 kg sodium hydroxide 0.160 kg and water 49.690 kg
L-methionine 1.500 kg glycerol 2.500 kg atch carraghenate 1.300 kg
IV preservative 0.600 kg
I protein 0.300 kg
Example 4
According to the same procedure as described in Example 1, composition was prepared from the following ingredients:
j paraffinic oil I 12 .000 kg paraffinic oil II 3 .400 kg
Batch mono- and diglycerides 2 .200 kg I ethoxylated triglycerides 0 .060 kg
Iquaternary modified montmorillonite 0 .640 kg and vitamin E acetate, D-isomer 2 .300 kg
Batch perfume (sage oil) 0 400 kg II perfume (jacaranda) 0 080 kg and water 21 900 kg
Batch citric acid 1 130 kg III zmc carbonate 0 700 kg sodium hydroxide (97 % 0 160 kg and r.water 50 250 kg
D,L-methιonιne 2 000 kg glycerol 2 000 kg
Batch preservative 0. 600 kg IV protein 0. 380 kg H
The hereinbefore specified compositions show a high stability and a fast healing, relieving and softening activity when applied on sore, chapped and/or inflamed skin of lips and nose opening edges .

Claims

Claims
1. Multifunctional composition for the treatment of chapped, sore and/or inflamed skin parts such as lips, nose opening edges, eyelids and the like, characterized by at least the following ingredients:
(a) An oil fraction comprising straight or branched paraffinic oils, having from 10 to 60 carbon atoms in the chain, in an amount of from 10 to 60 % by weight, relative to the weight of the complete composition, having a boiling range between 100 and 500°C at atmospheric pressure and a viscosity of at most 35 mm^/s at 25°C, while the paraffinic oils may optionally be mixed with esters of higher natural fatty acids, which are preferably unsaturated, and of higher natural aliphatic alcohols, which are preferably unsaturated, of at most 20 carbon atoms in the chain, in an amount of from 0 to 2 % by weight, relative to the weight of the complete composition;
(b) an emulsifying system mainly comprising
(b,ι) mono- and/or diglycerides of higher unsaturated natural fatty acids, in an amount of from 0.5 to 3 % by weight, relative to the weight of the complete composition, and
(b.ii) ethoxylated triglycerides esterified with fatty acid, according to the general formula
Figure imgf000018_0001
wherein n, m and p represent the same or different integers of from 0 to 20, under the condition that at least one of the symbols n, m and p has a value of from 5 to 20, preferably from 7 to 15, and wherein R represents the same or different saturated or unsaturated, and preferably the same unsaturated hydrocarbon residue, derived from vegetable or animal oil,
whereby the weight ratio between the amount of mono- and/or diglycerides on the one hand and of the ethoxylated triglycerides on the other hand may vary from 10 to 100 parts by weight of mono- and/or diglycerides per part by weight of ethoxylated triglycerides, whereas the amount of the complete emulsifying system, relative to the weight of the complete composition, may vary from 0.5 to 3,5 % by weight.
(c) vitamin E, or a derivative thereof which may easily provide vitamin E itself by conversion on the affected skin in an amount of from 0.1 to 5 % by weight, relative to the weight of the total composition; (d) methionine, in the form of its L or D isomer or mixtures thereof, preferably L-methionine, cr a derivative thereof which may easily provide methionine by conversion on the affected skin, n an amount of from 0.1 to 5 % by weight, relative to the weight of the complete composition;
(e) a pH regulating system to adjust the pH of a present aqueous phase including at least demmeralized water and methionine, to be in the range of from 4 4 to 5.0, comprising preferably citric acid, zinc carbonate and sodium hydroxide or citric acid, z nc carbonate and potassium hydroxide, each of the components occurring n an amount of from 0.05 to
2.5 % by weight, relative to the weight of the complete composition;
(f) a stabilizer consisting of at least one montmorillonite the free oxygen sites of which are occupied by quaternary groups in an amount of from 0.1 to 1.5 % by weight, relative to the weight cf the complete composition;
(g) water ad 100 % by weight.
2. Composition according to claim 1, comprising
(a) an o l fraction, comprising straight or branched paraffinic oils in an amount of from 15 to 25 % by weight, mixed with esters of unsaturated higher natural aliphatic alcohols in an amount of from 0.5 to 2 % oy weight;
(b) an emulsifying system mainly comprising (b,i) mono- and/or diglycerides of higher unsaturated and saturated fatty acids, in an amount of from 0.5 to 3 % by weight,
5 (b,ii) ethoxylated triglycerides according to the general formula of claim 1 wherein n, m and p are the same or different and each has a value from 7 to 15, and R is defined as in claim 1,
0 whereby the weight ratio between the amount of mono-, and/or diglycerides and of the ethoxylated triglycerides is in the range of from 15 to 50 parts by weight of mono- and/or diglycerides per part by weight of ethoxylated triglycerides, whereas the i amount of the complete emulsifying system, relative to the weight of the complete composition, is in the range of from 2 to 3.5 % by weight;
(c) vitamin E in an amount of from 1 to 3 % by weight, 0 relative to the weight of the complete composition;
d) L-methionine in an amount of from 1 to 2 % by weight;
(e) a pH regulating system to adjust the pH of the 5 aqueous system to be in the range of from 4.5 to 4.9, comprising citric acid, zinc carbonate and sodium hydroxide in amounts of 0.5 to 2 % by weight, from 0.5 to 1 % by weight and 0.05 to 0.2 % by weight, respectively; 0
(f) the stabilizer in an amount of from 0.5 to 0.7 % by weight;
(g) water ad 100 % by weight. c 3. Composition according to claims 1 or 2, comprising additionally:
(h) at least one preservative in an amount of from 0.1 to 1 % by weight, preferably from 0.5 to 0.7 % by weight, relative to the weight of the complete composition;
(i) glycerol in an amount of from 1 to 4 % by weight, preferably from 1 to 3 % by weight, relative to the weight of the complete composition;
(j) a gel forming agent in an amount of from 0.1 to 5 % by weight, preferably from 0.5 to 2 % by weight, relative to the weight of the complete composition;
(k) perfume in an amount of from 0.1 to 2 % by weight, relative to the weight of the complete composition;
(1) at least one protein, obtainable from aqueous extraction of plants, such as aloe vera, in an amount of from 0.1 to 0.5 % by weight, preferably from 0.1 to 0.
3 % by weight, relative to the weight of the complete composition.
4. Process for the preparation of a composition according to any of claims 1 to 3, characterized by the preparation in one or more steps of the complete continuous oily phase, composed of the oil fraction, the optional esters of fatty acids and alcohols, the emulsifying system, the stabilizer, vitamin E or a derivative thereof, the perfume and the optional preservative, and by the preparation in one or more steps of at least one dispersed aqueous phase composed of demineralized water, citric acid or a citrate, zinc carbonate and sodium or potassium hydroxide, methionine, glycerol, gel forming agent, protein, and preservative, and by mixing together both phases at a temperature in the range of from 10 to 40°C, followed by additional stirring and homogenizing until an average particle size of the dispersed aqueous phase of at most 5 μ, and preferably smaller than 3 μ, is reached, while the pH of the final complete composition is adjusted within the range of from 4.8 to 5.1.
Process according to claim 4, characterized in that
in a first step the oil fraction, the optional esters of fatty acids and alcohols, the emulsifying system and the stabilizer are mixed and homogenized at a temperature from 60 to 90°C, whereafter the homogeneous mixture is cooled back to a temperature of at most 30°C,
whereafter the cooled mixture is mixed in a second step with vitamin E or a derivative thereof which can easily be transformed into said vitamin, and with the perfume until a homogeneous mixture is obtained;
and that the aqueous phase is prepared by subsequent addition of demineralized water in an amount of about one third of the total amount in the final composition, of citric acid, of zinc carbonate and of sodium or potassium hydroxide under gently stirring until complete dissolution, whereafter, if necessary, the pH of the homogeneous solution is adjusted to the range of from 4.6 to 4.8 by addition of sodium or potassium hydroxide or citric acid, and the remainder of the desired total amount of water, methionine, glycerol, carreghenate, preservative and protein are added to the aqueous solution, whereafter the pH is again adjusted to the range of from 4.6 to 4.8, and that the finally obtained aqueous solution is added to the oily phase under stirring vigorously and subsequent homogenizing at a temperature in the range of from 10 to 40°C, preferably from 20 to 30°C, whereafter the pH of the complete dispersion, having dispersed aqueous phase particles of an average size of at most 5 μ is in the range of from 4.9 to 5.1.
6. Use of a composition according to any of claims 1 to 3, comprising the application and evenly spreading on chapped, sore and/or inflamed lips, nose opening edges, eyelids and the like, of said composition in an amount of from 20 to 100 ml/m2 skin area.
PCT/EP1997/000269 1996-01-23 1997-01-21 Composition for treating skin affections and process for its preparation WO1997026917A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP97902196A EP0876159A1 (en) 1996-01-23 1997-01-21 Composition for treating skin affections and process for its preparation
AU15936/97A AU1593697A (en) 1996-01-23 1997-01-21 Composition for treating skin affections and process for its preparation
NO983215A NO983215L (en) 1996-01-23 1998-07-13 Compositions for the treatment of skin effects and methods for its preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96100928.9 1996-01-23
EP96100928 1996-01-23

Publications (1)

Publication Number Publication Date
WO1997026917A1 true WO1997026917A1 (en) 1997-07-31

Family

ID=8222427

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/000269 WO1997026917A1 (en) 1996-01-23 1997-01-21 Composition for treating skin affections and process for its preparation

Country Status (4)

Country Link
EP (1) EP0876159A1 (en)
AU (1) AU1593697A (en)
NO (1) NO983215L (en)
WO (1) WO1997026917A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0919224A1 (en) * 1997-10-20 1999-06-02 Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. Cleaning nose oil
WO2005087195A2 (en) * 2004-03-18 2005-09-22 Panacea Biotec Ltd. Novel compositions for topical delivery
WO2006067945A1 (en) * 2004-12-22 2006-06-29 Pola Chemical Industries Inc. External skin agent comprising modified clay for preventing inflammation
CN102481278A (en) * 2009-09-14 2012-05-30 株式会社资生堂 Composition for alleviating ultraviolet radiation-induced damage
WO2013190095A3 (en) * 2012-06-21 2014-07-03 L'oreal Matt-effect composition comprising hydrophobic aerogel particles and an oxyethylenated nonionic surfactant
US20220370344A1 (en) * 2014-09-17 2022-11-24 Aldo Laghi Topical Composition Containing Antioxidants

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007120A1 (en) * 1978-06-30 1980-01-23 Chemisch Adviesbureau Drs. J.C.P.Schreuder Handwashing composition and a process for its preparation
JPS5916816A (en) * 1982-07-16 1984-01-28 Lion Corp Composition for external use
EP0138262A2 (en) * 1983-09-26 1985-04-24 Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. Composition for treatment of skin affections and its application
EP0203211A1 (en) * 1985-05-28 1986-12-03 Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. Composition for treatment of skin affections and process for its preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007120A1 (en) * 1978-06-30 1980-01-23 Chemisch Adviesbureau Drs. J.C.P.Schreuder Handwashing composition and a process for its preparation
JPS5916816A (en) * 1982-07-16 1984-01-28 Lion Corp Composition for external use
EP0138262A2 (en) * 1983-09-26 1985-04-24 Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. Composition for treatment of skin affections and its application
EP0203211A1 (en) * 1985-05-28 1986-12-03 Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. Composition for treatment of skin affections and process for its preparation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 100, no. 18, 30 April 1984, Columbus, Ohio, US; abstract no. 144838k, "Cosmetics containing vitamin E analogs and Aloe extracts for skin cracking control" page 352; column 1; XP002006657 *
DATABASE WPI Section Ch Week 8410, Derwent World Patents Index; Class B03, AN 84-59244 *
PATENT ABSTRACTS OF JAPAN vol. 8, no. 102 (C - 222) 12 May 1984 (1984-05-12) *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0919224A1 (en) * 1997-10-20 1999-06-02 Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. Cleaning nose oil
AU2005221427B2 (en) * 2004-03-18 2008-09-25 Panacea Biotec Ltd. Novel compositions for topical delivery
WO2005087195A2 (en) * 2004-03-18 2005-09-22 Panacea Biotec Ltd. Novel compositions for topical delivery
WO2005087195A3 (en) * 2004-03-18 2006-08-03 Panacea Biotec Ltd Novel compositions for topical delivery
EA011244B1 (en) * 2004-03-18 2009-02-27 Панацея Биотек Лтд. Novel compositions for topical delivery
AU2011200366B2 (en) * 2004-12-22 2011-10-13 Pola Chemical Industries Inc. External skin agent comprising modified clay for preventing inflammation
JP2008524115A (en) * 2004-12-22 2008-07-10 ポーラ化成工業株式会社 Inflammation-preventing skin external preparation containing modified clay
AU2005317496B2 (en) * 2004-12-22 2010-10-28 Pola Chemical Industries Inc. External skin agent comprising modified clay for preventing inflammation
WO2006067945A1 (en) * 2004-12-22 2006-06-29 Pola Chemical Industries Inc. External skin agent comprising modified clay for preventing inflammation
KR101228862B1 (en) * 2004-12-22 2013-02-05 포라 가세이 고교 가부시키가이샤 External skin agent comprising modified clay for preventing inflammation
US8741323B2 (en) 2004-12-22 2014-06-03 Pola Chemical Industries Inc. External skin agent comprising modified clay for preventing inflammation
CN102481278A (en) * 2009-09-14 2012-05-30 株式会社资生堂 Composition for alleviating ultraviolet radiation-induced damage
TWI473624B (en) * 2009-09-14 2015-02-21 Shiseido Co Ltd D-methionine and its salts are used in the manufacture of methods for reducing the UV damage composition
WO2013190095A3 (en) * 2012-06-21 2014-07-03 L'oreal Matt-effect composition comprising hydrophobic aerogel particles and an oxyethylenated nonionic surfactant
US20220370344A1 (en) * 2014-09-17 2022-11-24 Aldo Laghi Topical Composition Containing Antioxidants
US11806427B2 (en) * 2014-09-17 2023-11-07 Alps South Europe, S.R.O. Topical composition containing antioxidants

Also Published As

Publication number Publication date
NO983215L (en) 1998-09-17
AU1593697A (en) 1997-08-20
EP0876159A1 (en) 1998-11-11
NO983215D0 (en) 1998-07-13

Similar Documents

Publication Publication Date Title
DE69001730T2 (en) PASTE-SHAPED, AQUEOUS PHARMACEUTICAL COMPOSITIONS.
DE69636342T2 (en) LIPONIC ACID IN TOPICAL AGENTS
DE69732977T2 (en) STABILIZED ASCORBYL COMPOSITIONS
US5741496A (en) Process for the treatment of skins having dry areas and greasy areas
USRE33845E (en) Novel skin tanning composition
GB2130486A (en) Anti-acne compositions based on benzoyl peroxide
CN1249926A (en) Emulsion containing hydrophilic thickening compound and thickening copolymer and composition containing the said emulsion
EP0138262B1 (en) Composition for treatment of skin affections and its application
JP3489703B2 (en) Fine emulsion composition
KR20140146047A (en) Anti-stretch mark skin cream and method for making and using thereof
JP3432848B2 (en) Hair restorer
US5032408A (en) Composition for treatment of skin affections and process for its preparation
JPH0624953A (en) Cosmetic use of composition with antierythema activity and corresponding composition
WO1997026917A1 (en) Composition for treating skin affections and process for its preparation
JPH0751491B2 (en) Emulsified cosmetics containing crude drugs
CA2376850C (en) Topical formulations comprising skin penetration agents and the use thereof
SK15142000A3 (en) Cosmetic and pharmaceutical creams in the form of an oil in water
JP2008273941A (en) Adapalene-containing external agent composition
KR100305186B1 (en) Silicone Emulsion Type Water Soluble Gel Cosmetic Composition With Excellent Sebum Control And Cosmetic Persistence
EP0914817A1 (en) Nipple ointment composition
EP0383162A1 (en) Use of a mixture of active substances in the treatment of rheumatic diseases
EP0124665B1 (en) Dermatological compositions
JPH08165230A (en) Cosmetic
SU878292A1 (en) Cream for skin
RU2083198C1 (en) Face cream

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997902196

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997902196

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97526520

Format of ref document f/p: F

WWW Wipo information: withdrawn in national office

Ref document number: 1997902196

Country of ref document: EP